Tag #Biotech Funding

Showing 1 to 2 of 2 results

forbes.com
🌐 85% Global Worthiness
News related image

Halozyme Sues Merck Over Injectable Keytruda

Merck's new injectable Keytruda faces a lawsuit from Halozyme, delaying its planned October 1 launch and highlighting upcoming patent expirations in 2028. The suit challenges Merck's use of Halozyme's hyaluronidase technology in the new injectable formulation, and Merck has said it is meritless.

Progress

40% Bias Score

Good Health and Well-being
cincodias.elpais.com
🌐 65% Global Worthiness
News related image

Oryzon Genomics Raises €30 Million, Bolsters Nasdaq Bid

Oryzon Genomics, a Spanish pharmaceutical company, raised €30 million in an accelerated capital increase led by a US institutional investor, exceeding its initial target, to support its potential Nasdaq dual listing and advance its clinical programs.

Progress

44% Bias Score

Decent Work and Economic Growth

Showing 1 to 2 of 2 results